EP1408050A1 - A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue - Google Patents
Peptide sequences and molecular structures of FDA approved GLP-1 RAs. | Download Scientific Diagram
Figure 1 | Polymer-Based Delivery of Glucagon-Like Peptide-1 for the Treatment of Diabetes
Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists - ScienceDirect
The amino acid sequence of GLP-1, liraglutide and exenatide. Amino... | Download Scientific Diagram
Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology - Brandt - 2018 - Journal of Internal Medicine - Wiley Online Library
Amino acid sequence of GLP-1 (a) and exenatide (b). | Download Scientific Diagram
Design of modified mature human GLP-1 (mGLP-1). The amino acid sequence... | Download Scientific Diagram
New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs - Chen Gilor, Adam J Rudinsky, Melanie J Hall, 2016
Amino Acid Structure of Native Human GLP-1 and Liraglutide. | Download Scientific Diagram
Efficient synthesis of Aib8‐Arg34‐GLP‐1 (7–37) by liquid‐phase fragment condensation - Zhang - 2022 - Journal of Peptide Science - Wiley Online Library
Long Acting GLP-1 Receptor Agonist Drugs Lists and Overview | Biopharma PEG
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease | Scientific Reports
Figure 1.3 from Cardiovascular Effects and Mechanism(s) of Action of Glucagon-Like Peptide-1 Metabolite, GLP-1(28-36) | Semantic Scholar
Sequences of GLP-1, glucagon, GIP, OXM, and clinically available GLP-1... | Download Scientific Diagram
Figure 2 from Novel Therapeutic Approaches in Diabetes. | Semantic Scholar
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes | ACS Medicinal Chemistry Letters
GLP-1R Signaling | Encyclopedia MDPI
Structures of GLP-1 48 and the GLP-1 receptor agonists lir- aglutide 49... | Download Scientific Diagram
I-M-150847, a novel GLP-1 and GIP receptor dual agonist, improves glycemic control and reduces obesity in the rodent model of type 2 diabetes and obesity | bioRxiv
Molecular interaction between GLP-1 and GLP1R. The amino acid sequences... | Download Scientific Diagram
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes | Gene Therapy
Amino acid sequence alignment of GLP-1 and its family peptides. Amino... | Download Scientific Diagram
IJMS | Free Full-Text | A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
Newer GLP-1 receptor agonists and obesity-diabetes - ScienceDirect
